213 related articles for article (PubMed ID: 34873829)
1. RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination.
Rong G; Pan Z; Ding M; Wang L
Environ Toxicol; 2022 Mar; 37(3):603-611. PubMed ID: 34873829
[TBL] [Abstract][Full Text] [Related]
2. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
Xu Y; Feng Y; Sun Z; Li Q
Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
[TBL] [Abstract][Full Text] [Related]
3. Ubiquilin 1 suppresses the cancer stem cell-like traits of non-small cell lung cancer cells by regulating reactive oxygen species homeostasis.
Liu T; Ma Q; Li W; Hu Y; Yang J; Yao Q
Bioengineered; 2021 Dec; 12(1):7143-7155. PubMed ID: 34546848
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
[TBL] [Abstract][Full Text] [Related]
5. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer.
Tan B; Zhang J; Wang W; Ma H; Yang Y
Apoptosis; 2023 Apr; 28(3-4):397-413. PubMed ID: 36436119
[TBL] [Abstract][Full Text] [Related]
7. Quercetin-induced degradation of RhoC suppresses hepatocellular carcinoma invasion and metastasis.
Huang C; Lai W; Mao S; Song D; Zhang J; Xiao X
Cancer Med; 2024 Feb; 13(4):e7082. PubMed ID: 38457248
[TBL] [Abstract][Full Text] [Related]
8. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
Islam M; Sharma S; Teknos TN
PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
[TBL] [Abstract][Full Text] [Related]
9. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
[TBL] [Abstract][Full Text] [Related]
11. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells.
Wu Z; Liu H; Sun W; Du Y; He W; Guo S; Chen L; Zhao Z; Wang P; Liang H; Deng J
Cell Death Dis; 2020 Oct; 11(10):881. PubMed ID: 33082325
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4.
Lu C; Ning G; Si P; Zhang C; Liu W; Ge W; Cui K; Zhang R; Ge S
Biochem Cell Biol; 2021 Oct; 99(5):675-681. PubMed ID: 33529121
[TBL] [Abstract][Full Text] [Related]
13. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
14. Activation of RhoC by regulatory ubiquitination is mediated by LNX1 and suppressed by LIS1.
Kholmanskikh S; Singh S; Ross ME
Sci Rep; 2022 Oct; 12(1):16493. PubMed ID: 36192543
[TBL] [Abstract][Full Text] [Related]
15. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target.
Thomas P; Pranatharthi A; Ross C; Srivastava S
J Exp Clin Cancer Res; 2019 Jul; 38(1):328. PubMed ID: 31340863
[TBL] [Abstract][Full Text] [Related]
16. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
Xiao X; Rui B; Rui H; Ju M; Hongtao L
Environ Toxicol; 2022 Mar; 37(3):504-513. PubMed ID: 34837450
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MCF2L-AS1 promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulating miR-873-5p level.
Li S; Lin L
Environ Toxicol; 2021 Jul; 36(7):1457-1465. PubMed ID: 33783940
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
Wang R; Dong HX; Zeng J; Pan J; Jin XY
J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
[TBL] [Abstract][Full Text] [Related]
19. Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation.
Li M; Zhong Y; Wang M
Environ Toxicol; 2021 Nov; 36(11):2333-2341. PubMed ID: 34390292
[TBL] [Abstract][Full Text] [Related]
20. RNF168 is highly expressed in esophageal squamous cell carcinoma and contributes to the malignant behaviors in association with the Wnt/β-catenin signaling pathway.
Gou Y; Jin D; He S; Han S; Bai Q
Aging (Albany NY); 2021 Jan; 13(4):5403-5414. PubMed ID: 33493132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
